TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Clinical trial NCT06051253 · RECRUITING

Trial details

NCT number: NCT06051253
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease Infliximab Perianal Fistula Due to Crohn's Disease Therapeutic Drug Monitoring Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score

Start date: 2023-11-01
Primary completion: 2026-06-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.